Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice
- PMID: 11430801
- DOI: 10.1016/s0896-6273(01)00317-8
Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice
Abstract
Inhibition of neocortical beta-amyloid (Abeta) accumulation may be essential in an effective therapeutic intervention for Alzheimer's disease (AD). Cu and Zn are enriched in Abeta deposits in AD, which are solubilized by Cu/Zn-selective chelators in vitro. Here we report a 49% decrease in brain Abeta deposition (-375 microg/g wet weight, p = 0.0001) in a blinded study of APP2576 transgenic mice treated orally for 9 weeks with clioquinol, an antibiotic and bioavailable Cu/Zn chelator. This was accompanied by a modest increase in soluble Abeta (1.45% of total cerebral Abeta); APP, synaptophysin, and GFAP levels were unaffected. General health and body weight parameters were significantly more stable in the treated animals. These results support targeting the interactions of Cu and Zn with Abeta as a novel therapy for the prevention and treatment of AD.
Comment in
-
Metal chelator decreases Alzheimer beta-amyloid plaques.Neuron. 2001 Jun;30(3):641-2. doi: 10.1016/s0896-6273(01)00330-0. Neuron. 2001. PMID: 11430794 Review.
Similar articles
-
Metal chelator decreases Alzheimer beta-amyloid plaques.Neuron. 2001 Jun;30(3):641-2. doi: 10.1016/s0896-6273(01)00330-0. Neuron. 2001. PMID: 11430794 Review.
-
Clioquinol reduces zinc accumulation in neuritic plaques and inhibits the amyloidogenic pathway in AβPP/PS1 transgenic mouse brain.J Alzheimers Dis. 2012;29(3):549-59. doi: 10.3233/JAD-2011-111874. J Alzheimers Dis. 2012. PMID: 22269164
-
Copper and clioquinol treatment in young APP transgenic and wild-type mice: effects on life expectancy, body weight, and metal-ion levels.J Mol Med (Berl). 2007 Apr;85(4):405-13. doi: 10.1007/s00109-006-0140-7. Epub 2007 Jan 9. J Mol Med (Berl). 2007. PMID: 17211610
-
Effects of clioquinol on metal-triggered amyloid-beta aggregation revisited.Inorg Chem. 2009 Oct 19;48(20):9596-8. doi: 10.1021/ic9014256. Inorg Chem. 2009. PMID: 19817493
-
'...and C is for Clioquinol' - the AbetaCs of Alzheimer's disease.Trends Neurosci. 2002 Mar;25(3):121-3; discussion 123-4. doi: 10.1016/s0166-2236(00)02086-5. Trends Neurosci. 2002. PMID: 11852134 Review.
Cited by
-
Treatment with 1, 10 Phenanthroline-5-Amine Reduced Amyloid Burden in a Mouse Model of Alzheimer's Disease.J Alzheimers Dis. 2024;97(1):239-247. doi: 10.3233/JAD-221285. J Alzheimers Dis. 2024. PMID: 38073385 Free PMC article.
-
A chromogenic diarylethene-based probe for the detection of Cu2+ in aqueous medium in Drosophila for early diagnosis of Alzheimer.Heliyon. 2024 Jan 4;10(1):e24074. doi: 10.1016/j.heliyon.2024.e24074. eCollection 2024 Jan 15. Heliyon. 2024. PMID: 38230249 Free PMC article.
-
Alzheimer's Drug PBT2 Interacts with the Amyloid β 1-42 Peptide Differently than Other 8-Hydroxyquinoline Chelating Drugs.Inorg Chem. 2022 Sep 19;61(37):14626-14640. doi: 10.1021/acs.inorgchem.2c01694. Epub 2022 Sep 8. Inorg Chem. 2022. PMID: 36073854 Free PMC article.
-
Zinc Inhibits Amyloid beta Production from Alzheimer's Amyloid Precursor Protein in SH-SY5Y Cells.Korean J Physiol Pharmacol. 2009 Jun;13(3):195-200. doi: 10.4196/kjpp.2009.13.3.195. Epub 2009 Jun 30. Korean J Physiol Pharmacol. 2009. PMID: 19885037 Free PMC article.
-
The native copper- and zinc-binding protein metallothionein blocks copper-mediated Abeta aggregation and toxicity in rat cortical neurons.PLoS One. 2010 Aug 11;5(8):e12030. doi: 10.1371/journal.pone.0012030. PLoS One. 2010. PMID: 20711450 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous
